Get started
Author

Adrián Martín

Results of an analysis of cardiac function in 2,812 patients treated with lapatinib
2006 · E. A. Perez, J. A. Byrne, et al. · Journal of Clinical Oncology · 40
Limited T cell response to SARS-CoV-2 mRNA vaccine among patients with cancer receiving different cancer treatments
2022 · Alfonso Cortés, José L. Casado, et al. · European Journal of Cancer · 27
PDF
PGC-1α-Dependent Mitochondrial Adaptation Is Necessary to Sustain IL-2-Induced Activities in Human NK Cells
2016 · Dante Miranda, Claudia Jara, et al. · Mediators of Inflammation · 20
PDF
Investigation of tumor biomarkers as response predictors in a monotherapy study with lapatinib (L) as a first line treatment in ErbB2 amplified women with breast cancer
2007 · H. L. Gomez, M. A. Chavez, et al. · Journal of Clinical Oncology · 11
Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors
2023 · Cristina Saavedra, Alejandro Vallejo, et al. · Cancers · 3
PDF
Analysis of emergency head computed tomography in critically ill oncological patients
2021 · Cristian Pristavu, Adrian Martin, et al. · Radiology and Oncology · 1
PDF
The impact of cyclin-dependent kinases 4 and 6 inhibitors in the immune response to mRNA SARS-CoV-2 vaccine in women with breast cancer.
2022 · Cristina Saavedra, Alejandro Vallejo, et al. · Research Square
The impact of cyclin-dependent kinases 4 and 6 inhibitors in the immune response to mRNA SARS-CoV-2 vaccine in women with breast cancer.
2022 · Cristina Saavedra, Alejandro Vallejo, et al. · Research Square
PDF
Analysis of the Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Breast Cancer Patients Treated With Cyclin-Dependent Kinases 4 and 6 Inhibitors (CDKi): Limited T-Cell Immunity Despite Satisfactory Humoral Response.
2021 · Cristina Saavedra, Alejandro Vallejo, et al. · Research Square
PDF
Works count: 9
Citation count: 102
H-index: 4
I10-index: 4
Year
Topic
Type